Fibrosis Reduction

Fibrosis Reduction is a therapeutic strategy aimed at diminishing excessive extracellular matrix deposition and scar tissue formation within the tumor microenvironment to restore tissue architecture and improve treatment efficacy.

962

Publications

49.4K

Citations

6.7K

Authors

1.6K

Institutions

Publications per year

2017–2026

546

Authors

6.7K

  1. CD
    Chunsun Dai

    Nanjing Medical University, China

    10 publications · 606 citations

    10

    h-index

  2. JH
    Jörg H. W. Distler

    Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany

    8 publications · 971 citations

    8

    h-index

  3. SS
    Sen Shi

    Kanazawa Medical University, Japan

    7 publications · 662 citations

    7

    h-index

  4. DK
    Daisuke Koya

    Kanazawa Medical University, Japan

    6 publications · 847 citations

    6

    h-index

  5. SA
    Stephen A. Harrison

    Pinnacle Clinical Research, United States

    6 publications · 2.3K citations

    6

    h-index

1–5 of 6.7K

Venues

  1. PLoS ONE

    26 publications · 1.2K citations

    21

    h-index

  2. Scientific Reports

    20 publications · 753 citations

    18

    h-index

  3. PubMed

    Repository · 32 publications · 930 citations

    18

    h-index

  4. Hepatology

    16 publications · 1.4K citations

    16

    h-index

  5. Frontiers in Pharmacology

    20 publications · 600 citations

    16

    h-index

1–5